Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations. Kubler, K., Nardone, A., Anand, S., Gorvich, D., Droog, M., Hermida-Prado, F., Akshi, T., Feit, A. S, Cohen, G., Dackus, G., & others Cancer Research, 82(4_Supplement):GS2–09, The American Association for Cancer Research, 2022. bibtex @article{kubler2022abstract,
title={Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations},
author={Kubler, Kirsten and Nardone, Agostina and Anand, Shankara and Gorvich, Daniel and Droog, Marjolein and Hermida-Prado, Francisco and Akshi, Tara and Feit, Avery S and Cohen, Gabriella and Dackus, Gwen and others},
journal={Cancer Research},
volume={82},
number={4\_Supplement},
pages={GS2--09},
year={2022},
publisher={The American Association for Cancer Research}
}
Downloads: 0
{"_id":"4LMsJsgc2DoFCmwcy","bibbaseid":"kubler-nardone-anand-gorvich-droog-hermidaprado-akshi-feit-etal-abstractgs209tamoxifeninstigatesuterinecancerdevelopmentbyactivatingpi3ksignalingandsupersedespik3cadrivermutations-2022","author_short":["Kubler, K.","Nardone, A.","Anand, S.","Gorvich, D.","Droog, M.","Hermida-Prado, F.","Akshi, T.","Feit, A. S","Cohen, G.","Dackus, G.","others"],"bibdata":{"bibtype":"article","type":"article","title":"Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations","author":[{"propositions":[],"lastnames":["Kubler"],"firstnames":["Kirsten"],"suffixes":[]},{"propositions":[],"lastnames":["Nardone"],"firstnames":["Agostina"],"suffixes":[]},{"propositions":[],"lastnames":["Anand"],"firstnames":["Shankara"],"suffixes":[]},{"propositions":[],"lastnames":["Gorvich"],"firstnames":["Daniel"],"suffixes":[]},{"propositions":[],"lastnames":["Droog"],"firstnames":["Marjolein"],"suffixes":[]},{"propositions":[],"lastnames":["Hermida-Prado"],"firstnames":["Francisco"],"suffixes":[]},{"propositions":[],"lastnames":["Akshi"],"firstnames":["Tara"],"suffixes":[]},{"propositions":[],"lastnames":["Feit"],"firstnames":["Avery","S"],"suffixes":[]},{"propositions":[],"lastnames":["Cohen"],"firstnames":["Gabriella"],"suffixes":[]},{"propositions":[],"lastnames":["Dackus"],"firstnames":["Gwen"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["others"],"suffixes":[]}],"journal":"Cancer Research","volume":"82","number":"4_Supplement","pages":"GS2–09","year":"2022","publisher":"The American Association for Cancer Research","bibtex":"@article{kubler2022abstract,\n title={Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations},\n author={Kubler, Kirsten and Nardone, Agostina and Anand, Shankara and Gorvich, Daniel and Droog, Marjolein and Hermida-Prado, Francisco and Akshi, Tara and Feit, Avery S and Cohen, Gabriella and Dackus, Gwen and others},\n journal={Cancer Research},\n volume={82},\n number={4\\_Supplement},\n pages={GS2--09},\n year={2022},\n publisher={The American Association for Cancer Research}\n}\n\n","author_short":["Kubler, K.","Nardone, A.","Anand, S.","Gorvich, D.","Droog, M.","Hermida-Prado, F.","Akshi, T.","Feit, A. S","Cohen, G.","Dackus, G.","others"],"key":"kubler2022abstract","id":"kubler2022abstract","bibbaseid":"kubler-nardone-anand-gorvich-droog-hermidaprado-akshi-feit-etal-abstractgs209tamoxifeninstigatesuterinecancerdevelopmentbyactivatingpi3ksignalingandsupersedespik3cadrivermutations-2022","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/network/files/aX4e85mNvLnP28bmF","dataSources":["hky9vNrwc9uGBMQ9h"],"keywords":[],"search_terms":["abstract","gs2","tamoxifen","instigates","uterine","cancer","development","activating","pi3k","signaling","supersedes","pik3ca","driver","mutations","kubler","nardone","anand","gorvich","droog","hermida-prado","akshi","feit","cohen","dackus","others"],"title":"Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations","year":2022}